Clinical Trial Update: Bendamustine-based Combination Therapy for PCNSL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating bendamustine-based combination therapy for primary central nervous system lymphoma (PCNSL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• bendamustine-based combination therapy (bendamustine)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: PCNSL | Phase 2 | Status: UNKNOWN